Cargando…
Treatment outcomes of fixed-dose combination versus separate tablet regimens in pulmonary tuberculosis patients with or without diabetes in Qatar
BACKGROUND: Tuberculosis is considered the second most common cause of death due to infectious agent. The currently preferred regimen for treatment of pulmonary tuberculosis (PTB) is isoniazid, rifampin, pyrazinamide, and ethambutol, which has been used either as separate tablets (ST) or as fixed-do...
Autores principales: | Al-Shaer, Mohammad H., Mansour, Hanine, Elewa, Hazem, Salameh, Pascale, Iqbal, Fatima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290647/ https://www.ncbi.nlm.nih.gov/pubmed/28152986 http://dx.doi.org/10.1186/s12879-017-2231-1 |
Ejemplares similares
-
Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
por: Al-Shaer, Mohammad H., et al.
Publicado: (2018) -
Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
por: Wu, Jiun-Ting, et al.
Publicado: (2015) -
Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens
por: Clay, P.G., et al.
Publicado: (2015) -
Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar
por: Alhmoud, Eman, et al.
Publicado: (2020) -
A Survey on the Awareness and Attitude of Physicians on Direct Oral
Anticoagulants in Qatar
por: El-Bardissy, Ahmed, et al.
Publicado: (2018)